Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN68,9969,081,22
Msft2,32
Nokia4,3014,476-0,07
IBM2,46
Mercedes-Benz Group AG53,2153,231,58
PFE1,13
03.05.2025 0:30:52
Indexy online
AD Index online
select
AD Index online
 

  • 02.05.2025 17:35:01
Sartorius AG (SATG.DE, Xetra)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
192,20 3,67 6,80 862 832
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 03.05.2025
Popis společnosti
Obecné informace
Název společnostiSartorius AG
TickerSRT
TickerSRT3
Kmenové akcie:Ordinary Shares
Kmenové akcie:Preference Shares
RICSATG_p.DE
RICSATG.DE
ISINDE0007165607
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky31.03.2025
Počet zaměstnanců k 31.03.2025 13 573
Akcie v oběhu k 31.03.2025 69 038 196
MěnaEUR
Kontaktní informace
UliceOtto-Brenner-Str. 20
MěstoGOETTINGEN
PSČ37079
ZeměGermany
Kontatní osobaPetra Kirchhoff
Funkce kontaktní osobyMember of the Supervisory Board, Head of Corporate Communications & IR
Telefon 495 513 080
Fax495513083289
Kontatní telefon495 513 081 686

Business Summary: Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Sartorius AG revenues decreased less than 1% to EUR3.38B. Net income decreased 59% to EUR84M. Revenues reflect Bioprocess Solutions segment increase of less than 1% to EUR2.69B, France (Country) segment increase of 24% to EUR160.1M, Asia (Region)-China (Country) segment increase of 8% to EUR380.4M, also reflect Lab Products and Services segment decrease of 4% to EUR690.5M.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Diagnostic & Testing Equipment
RBSS2004Medical Equipment, Supplies & Distribution
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICSAnalytical Laboratory Instrument Manufacturing
NAICSOther Measuring and Controlling Device Manufacturing
NAICSOffices of Other Holding Companies
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Other Measuring & Controlling Device Mfg
NAICS2007Offices of Other Holding Companies
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Other Measuring and Controlling Device Manufacturing
NAICS1997Offices of Other Holding Companies
SICAnalytical Instruments
SICMeasuring/controlling Devices Nec
SICHolding Companies, Nec



  • Poslední aktualizace: 03.05.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Supervisory Board, Shareholder RepresentativeLothar Kappich6819.07.2017
Chairman of the Executive Board, Chief Executive OfficerJoachim Kreuzburg5931.03.202411.11.2002
Chief Executive Officer, Member of the Executive BoardMichael Grosse5701.07.202501.07.2025
Chief Financial Officer, Member of the Executive BoardFlorian Funck5301.04.202401.04.2024
Member of the Executive Board, Head - Bioprocess Solutions DivisionRene Faber4901.01.201901.01.2019
Member of the Executive Board, Head - Lab Products & Services DivisionAlexandra Gatzemeyer4501.05.202301.05.2023